ToF-SIMS analysis of chemical heterogenities in inkjet micro-array printed drug/polymer formulations

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 2, 2012, Pages 385-391

  Scoutaris, Nikolaos ^a   Hook, Andrew L ^a   Gellert, Paul R ^b   Roberts, Clive J ^a   Alexander, Morgan R ^a   Scurr, David J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE INGREDIENTS; CHEMICAL COMPONENT; CHEMICAL CONSTITUENTS; FELODIPINE; HYDROCHLOROTHIAZIDE; HYPER-SPECTRAL IMAGES; MICRO-DOT ARRAYS; MULTIVARIATE CURVE RESOLUTION; SUBSTRATE MATERIAL; TIME OF FLIGHT SECONDARY ION MASS SPECTROMETRY; TOF SIMS; TOF-SIMS ANALYSIS; UNIFORM DISTRIBUTION;

PHOSPHORUS; SECONDARY ION MASS SPECTROMETRY; SODIUM CHLORIDE; SULFUR;

CHEMICAL ANALYSIS;

FELODIPINE; HYDROCHLOROTHIAZIDE; PHOSPHOROUS ACID; POLY(VINYL PYROLIDONE); POLYGLACTIN; POLYMER; SODIUM CHLORIDE; SULFUR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; DRUG FORMULATION; MASS SPECTROMETRY; MICROARRAY ANALYSIS; PRINTING; PRIORITY JOURNAL; TIME OF FLIGHT SECONDARY ION MASS SPECTROMETRY;

CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; FELODIPINE; HYDROCHLOROTHIAZIDE; IONS; LACTIC ACID; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MODELS, CHEMICAL; POLYGLYCOLIC ACID; POLYMERS; POLYVINYLS; PRINTING; PYRROLIDINONES; SODIUM CHLORIDE; SPECTROMETRY, MASS, SECONDARY ION; SURFACE PROPERTIES;

EID: 84863424316     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4474-5     Document Type: Article

References (17)

1. Scoutaris N, Alexander MA, Gellert PR, Roberts CJ. Inkjet printing as a novel medicine formulation technique. J Control Release. 2011. doi:10.1016/j.jconrel.2011.07.033.
2. Chan KLA, Kazarian SG. Fourier transform infrared imaging for high-throughput analysis ofpharmaceutical formulations. J Comb Chem. 2005;7(2):185-9.
3. Cui XY, Hutt DA, Scurr DJ, Conway PP. The evolution of Pd/Sn catalytic surfaces in electroless copper deposition. J Electrochem Soc. 2011;58(3):D172-7.
4. Urquhart AJ, Taylor M, Anderson DG, Langer R, Davies MC, Alexander MR. TOF-SIMS analysis of a 576 micropatterned copolymer array to reveal surface moieties that control wetta-bility. Anal Chem. 2008;80(1):135-42.
5. Scurr DJ, Horlacher T, Oberli MA, Werz DB, Kroeck L, Bufali S, et al. Surface characterisation of carbohydrate microarrays. Langmuir. 2010;26(22):17143-55.
6. Belu AM, Davies MC, Newton JM, Patel N. TOF-SIMS char-acterisation and imaging of controlled-release drug delivery systems. Anal Chem. 2000;72(22):5625-38.
7. Lee JLS, Gilmore IS. The application of multivariate data anal-ysis techniques. In: Vickerman JC, Gilmore IS, editors. Surface analysis: the principal techniques. 2nd ed. Chichester: John Wiley & Sons Ltd; 2009.
8. Vervaet C, Remon JP. Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer. Pharm Res. 1997;14(11):1644-6.
9. Konno H, Taylor L. Ability of different polymers to inhibit the crystallisation of amorphous felodipine in the presence of mois-ture. Pharm Res. 2008;25(4):969-78.
10. Karavas E, Georgarakis M, Docoslis A, Bikiaris D. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix. Int J Pharm. 2007;340(1-2):76-83.
11. Kim E-J, Chun M-K, Jang J-S, Lee I-H, Lee K-R, Choi H-K. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm. 2006;64(2):200-5.
12. Konno Hajime, Taylor LS. Influence of different polymers on the crystallisation tendency of molecularly dispersed amorphous felodipine. J Pharm Sci. 2006;95(12):2692-705.
13. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, et al. Large porous particles for pulmonary drug delivery. Science. 1997;276(5320):1868-72.
14. Kim D-H, Martin DC. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials. 2006;27(15):3031-7.
15. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1): 5-24.
16. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Bio-materials. 2000;21(23):2475-90.
17. Tajber L, Corrigan OI, Healy AM. Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried compos-ites\-analysis of glass transition composition relationships. Eur J Pharm Sci. 2005;24(5):553-63.